Your browser doesn't support javascript.
loading
Efficacy and Safety of Candidate Biosimilar CT-P43 Versus Originator Ustekinumab in Moderate to Severe Plaque Psoriasis: 28-Week Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study.
Papp, Kim A; Lebwohl, Mark G; Thaçi, Diamant; Jaworski, Janusz; Kwiek, Bartlomiej; Trefler, Jakub; Dudek, Anna; Szepietowski, Jacek C; Reznichenko, Nataliya; Narbutt, Joanna; Baran, Wojciech; Kolinek, Joanna; Daniluk, Stefan; Bartnicka-Maslowska, Katarzyna; Reich, Adam; Andrashko, Yuriy; Kim, Sunghyun; Bae, Yunju; Jeon, Dabee; Jung, Jinsun; Lee, Hyunseung; Pyo, Tina; Ko, Woori.
Afiliação
  • Papp KA; Alliance Clinical Trials and Probity Medical Research Inc., 135 Union Street East, Waterloo, ON, N2J 1C4, Canada. kapapp@probitymedical.com.
  • Lebwohl MG; University of Toronto, Toronto, ON, Canada. kapapp@probitymedical.com.
  • Thaçi D; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Jaworski J; Institute and Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany.
  • Kwiek B; Centrum Medyczne Reuma Park NZOZ, Warsaw, Poland.
  • Trefler J; Klinika Ambroziak Dermatologia, Lazarski University, Warsaw, Poland.
  • Dudek A; Reuma Research, Warsaw, Poland.
  • Szepietowski JC; Centrum Medyczne AMED Warszawa Targowek, Warsaw, Poland.
  • Reznichenko N; Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland.
  • Narbutt J; Therapeutic Department, Military Hospital (Military Unit A3309) of Military-Medical Clinical Center of Eastern Region, Zaporizhzhia, Ukraine.
  • Baran W; Dermoklinika Centrum Medyczne s.c., Lódz, Poland.
  • Kolinek J; Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland.
  • Daniluk S; ClinicMed Daniluk, Nowak Spólka Jawna, Bialystok, Poland.
  • Bartnicka-Maslowska K; ClinicMed Daniluk, Nowak Spólka Jawna, Bialystok, Poland.
  • Reich A; Centrum Medyczne AMED Oddzial w Lodzi, Lódz, Poland.
  • Andrashko Y; Department of Dermatology, Institute of Medical Sciences, Medical College of Rzeszów University, Rzeszów, Poland.
  • Kim S; Outpatient Department, Treatment and Diagnostic Center of Private Enterprise 'Asklepiy', Uzhhorod National University, Uzhhorod, Ukraine.
  • Bae Y; Celltrion, Inc., Incheon, Republic of Korea.
  • Jeon D; Celltrion, Inc., Incheon, Republic of Korea.
  • Jung J; Celltrion, Inc., Incheon, Republic of Korea.
  • Lee H; Celltrion, Inc., Incheon, Republic of Korea.
  • Pyo T; Celltrion, Inc., Incheon, Republic of Korea.
  • Ko W; Celltrion, Inc., Incheon, Republic of Korea.
BioDrugs ; 38(1): 121-131, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37991693
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Medicamentos Biossimilares Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Medicamentos Biossimilares Idioma: En Ano de publicação: 2024 Tipo de documento: Article